Screening the Community for Individuals at Clinical High Risk (CHR) for Psychosis

对社区中患有精神病临床高危(CHR)的个体进行筛查

阅读:1

Abstract

INTRODUCTION: The aim of our study was to assess the performance of the Prodromal Questionnaire-16 (PQ-16) and the Perceptual and Cognitive Aberrations scale (PCA) to screen for clinical high risk for psychosis (CHR) in a sample of nonhelp-seeking subjects from São Paulo, Brazil. METHODS: Individuals aged 18-35 years were interviewed with the PQ-16 and the PCA. Those with a combined score > 10 on the PQ-16 + PCA were called for assessment with the Structured Interview for Psychosis-Risk Syndromes (SIPS). Seventy-five individuals were deemed as CHR and 99 as healthy comparison; 44 randomly selected individuals (PQ-16 + PCA scores < 10) joined as further controls. All participants had no DSM-5 diagnosis. Scores of the PCA, PQ-16 (total score and distress index), and their combinations were analysed. RESULTS: All the proposed scorings significantly distinguished between CHR and control subjects. Considering a 7% CHR prevalence in the population, PQ-16 score mathematically showed the best performance (AUC = 0.713), followed by the PQ-16 score + PCA (AUC = 0.701). PQ-16 distress had the worst performance (AUC = 0.642). CONCLUSIONS: Data provides further evidence for the use of the PQ-16 score as an effective instrument to search for CHR states through active screening in the community. Future research should address its potential in helping CHR identification and thus reducing delays in care and minimising the risk of false positives.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。